Doxycycline in Therapy of Erythema Migrans
- Registration Number
- NCT01475708
- Lead Sponsor
- University Medical Centre Ljubljana
- Brief Summary
The investigators will compare the outcome of three groups of erythema migrans patients treated with doxycycline: a group without any accompanying symptoms, with mild symptoms and with severe symptoms that require lumbar puncture.
- Detailed Description
Patients with erythema migrans treated with doxycycline for two weeks will be followed-up for one year (at 2 weeks, 2, 6 and 12 months) clinically and also by filling in the questionnaire to assess the presence of certain symptoms. Also the control group of their friends or relatives without a history of Lyme borreliosis will be included. The presence of their (unspecific) symptoms will also be recorded by the questionnaire at the time of enrollment and at 6 and 12 months.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 400
- presence of erythema migrans
- >15 years old
- informed consent
- pregnancy
- lactation
- multiple erythema migrans
- already treated with antibiotic for this episode of Lyme borreliosis
- allergy to doxycycline
- treatment with drugs with known interactions with doxycycline
- cerebrospinal fluid pleocytosis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description no symptoms Doxycycline patients with erythema migrans and no additional newly onset symptoms treated with doxycycline mild symptoms Doxycycline patients with erythema migrans and mild unspecific newly onset symptoms treated with doxycycline severe symptoms-lumbar puncture Doxycycline patients with erythema migrans and newly onset intense "neurologic" symptoms with lumbar puncture performed, treated with doxycycline
- Primary Outcome Measures
Name Time Method Comparing of objective sequelae and post-treatment subjective symptoms in three groups of erythema migrans patients treated with doxycycline: with no accompanying symptoms, with mild and with severe symptoms at the beginning. 1 year follow-up
- Secondary Outcome Measures
Name Time Method Comparison of subjective symptoms between erythema migrans patients treated with doxycycline and control subjects without a history of Lyme borreliosis. 1 year follow-up
Trial Locations
- Locations (1)
UMC Ljubljana, Department of Infectious Diseases
🇸🇮Ljubljana, Slovenia